Latest Transformation News

Iress Limited has reported a 19% increase in underlying earnings per share for its continuing business in the first half of 2025, completing a major transformation and reaffirming its full-year guidance despite revenue pressures from divestments.

Iress Limited reported a stable half-year profit for 2025, maintaining net earnings despite a slight revenue dip and ongoing divestments. The company strengthened its balance sheet through debt reduction and declared a healthy interim dividend, while exploring potential acquisition opportunities.

Minbos Resources has partnered exclusively with Fertiafrica to produce Angola’s first locally granulated fertilisers, aiming to transform the country’s agricultural landscape with affordable, high-quality products.

Global Health Limited has secured a $186,748 contract to implement its MasterCare+ digital platform at Jarrah House, enhancing alcohol and other drug (AOD) services with tailored technology solutions.

DigiCo Infrastructure REIT’s SYD1 data centre has achieved the highest Australian Government certification for secure data hosting, reinforcing its role in national digital infrastructure.

Lindian Resources has secured a major expansion of its mining licence in Malawi, setting the stage for a significant scale-up of its Kangankunde Rare Earths Project. This regulatory win, coupled with a strategic partnership with Iluka, could transform Lindian into a key player in the global rare earths market.

Linius Technologies has secured its first commercial contract for Captivate, a fan engagement platform that personalizes sports video experiences, with Honest Technology Partners. The deal guarantees over A$250,000 in revenue across two years, marking a significant milestone for Linius in the sports technology arena.

Cash Converters has expanded its Australian footprint by acquiring 14 franchise stores across key states, reinforcing its strategy to grow earnings and consumer lending.

Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.

Metro Performance Glass is set to strengthen its balance sheet and support its turnaround strategy through a $15 million to $24 million equity raise, with Amari Metals Australia poised to become the majority shareholder. This recapitalisation aims to reduce debt and improve operational focus amid challenging market conditions.

AVITA Medical has filed its Q2 2025 Form 10-Q, reaffirming its leadership in acute wound care with its FDA-approved RECELL System and expanding international footprint.

COSOL Limited reports FY25 revenue and EBITDA below guidance due to timing delays but highlights a 17% rise in operating cash flow and maintains optimistic FY26 growth forecasts.